Olympus Stock Fundamentals
OCPNF Stock | USD 16.00 0.00 0.00% |
Olympus fundamentals help investors to digest information that contributes to Olympus' financial success or failures. It also enables traders to predict the movement of Olympus Pink Sheet. The fundamental analysis module provides a way to measure Olympus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Olympus pink sheet.
Olympus |
Olympus Company Return On Equity Analysis
Olympus' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Olympus Return On Equity | 0.23 |
Most of Olympus' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Olympus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, Olympus has a Return On Equity of 0.2329. This is 100.97% lower than that of the Healthcare sector and 103.89% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is 175.13% lower than that of the firm.
Olympus Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Olympus's current stock value. Our valuation model uses many indicators to compare Olympus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Olympus competition to find correlations between indicators driving Olympus's intrinsic value. More Info.Olympus is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.35 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Olympus is roughly 2.86 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Olympus' earnings, one of the primary drivers of an investment's value.Olympus Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Olympus' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Olympus could also be used in its relative valuation, which is a method of valuing Olympus by comparing valuation metrics of similar companies.Olympus is currently under evaluation in return on equity category among its peers.
Olympus Fundamentals
Return On Equity | 0.23 | |||
Return On Asset | 0.0815 | |||
Current Valuation | 25.72 B | |||
Shares Outstanding | 1.27 B | |||
Shares Owned By Insiders | 4.42 % | |||
Shares Owned By Institutions | 59.82 % | |||
Price To Earning | 29.76 X | |||
Price To Book | 5.27 X | |||
Price To Sales | 0.03 X | |||
Revenue | 868.87 B | |||
Gross Profit | 571.7 B | |||
EBITDA | 219.64 B | |||
Net Income | 115.74 B | |||
Cash And Equivalents | 299.09 B | |||
Cash Per Share | 234.94 X | |||
Total Debt | 333.85 B | |||
Debt To Equity | 0.68 % | |||
Current Ratio | 1.99 X | |||
Book Value Per Share | 400.75 X | |||
Cash Flow From Operations | 169.73 B | |||
Earnings Per Share | 0.75 X | |||
Target Price | 48.18 | |||
Number Of Employees | 31.56 K | |||
Beta | 0.69 | |||
Market Capitalization | 23.62 B | |||
Total Asset | 1.36 T | |||
Retained Earnings | 189.37 B | |||
Working Capital | 213.76 B | |||
Current Asset | 464.59 B | |||
Current Liabilities | 250.83 B | |||
Annual Yield | 0.01 % | |||
Net Asset | 1.36 T |
About Olympus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Olympus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Olympus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Olympus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Olympus Corporation manufactures and sells precision machineries and instruments worldwide. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan. Olympus Corp operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 31557 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Olympus Pink Sheet
Olympus financial ratios help investors to determine whether Olympus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Olympus with respect to the benefits of owning Olympus security.